WHAT IS NICER?
Erasmus Medical Center and iMTA have started the Netherlands Initiative for Cost-Effectiveness Research (NICER), a pilot study and collaboration between clinicians and health economists. The first edition of NICER focusses on treatment sequence models for multiple myeloma, melanoma and multiple sclerosis. We also explore new purchasing paradigms for drugs in collaboration with the Rotterdam School of Management.
The first live broadcast from Erasmus Studio is in Dutch and is scheduled for the 22nd of October at 15:00 Amsterdam time. During this talkshow we shall discuss the results of the pilot with clinicians and purchasing professionals. The talkshow is freely accessible to all interested viewers. You can view the session here. The program [Dutch] can be found here.
Directly after the live broadcast on the 22nd, the NICER website will be launched at http://nicer.imta.nl